398 related articles for article (PubMed ID: 16269092)
1. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.
Carter OL; Burr DC; Pettigrew JD; Wallis GM; Hasler F; Vollenweider FX
J Cogn Neurosci; 2005 Oct; 17(10):1497-508. PubMed ID: 16269092
[TBL] [Abstract][Full Text] [Related]
2. Effects of psilocybin on time perception and temporal control of behaviour in humans.
Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX
J Psychopharmacol; 2007 Jan; 21(1):50-64. PubMed ID: 16714323
[TBL] [Abstract][Full Text] [Related]
3. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
4. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
Kometer M; Schmidt A; Jäncke L; Vollenweider FX
J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
[TBL] [Abstract][Full Text] [Related]
5. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.
Quednow BB; Kometer M; Geyer MA; Vollenweider FX
Neuropsychopharmacology; 2012 Feb; 37(3):630-40. PubMed ID: 21956447
[TBL] [Abstract][Full Text] [Related]
6. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.
Carter OL; Hasler F; Pettigrew JD; Wallis GM; Liu GB; Vollenweider FX
Psychopharmacology (Berl); 2007 Dec; 195(3):415-24. PubMed ID: 17874073
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
[TBL] [Abstract][Full Text] [Related]
8. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Wingen M; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
[TBL] [Abstract][Full Text] [Related]
10. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.
Carter OL; Pettigrew JD; Hasler F; Wallis GM; Liu GB; Hell D; Vollenweider FX
Neuropsychopharmacology; 2005 Jun; 30(6):1154-62. PubMed ID: 15688092
[TBL] [Abstract][Full Text] [Related]
11. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
Carli M; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
[TBL] [Abstract][Full Text] [Related]
12. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX
Biol Psychiatry; 2012 Dec; 72(11):898-906. PubMed ID: 22578254
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.
Barrett FS; Carbonaro TM; Hurwitz E; Johnson MW; Griffiths RR
Psychopharmacology (Berl); 2018 Oct; 235(10):2915-2927. PubMed ID: 30062577
[TBL] [Abstract][Full Text] [Related]
14. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
Vollenweider FX; Vollenweider-Scherpenhuyzen MF; Bäbler A; Vogel H; Hell D
Neuroreport; 1998 Dec; 9(17):3897-902. PubMed ID: 9875725
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks.
Ruotsalainen S; Sirviö J; Jäkälä P; Puumala T; MacDonald E; Riekkinen P
Eur Neuropsychopharmacol; 1997 May; 7(2):99-108. PubMed ID: 9169297
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic-serotonergic drug interactions and attentional performance in rats.
Rezvani AH; Caldwell DP; Levin ED
Psychopharmacology (Berl); 2005 May; 179(3):521-8. PubMed ID: 15682310
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M
Neuropsychobiology; 2002; 45(4):205-12. PubMed ID: 12097810
[TBL] [Abstract][Full Text] [Related]
19. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
Vollenweider FX; Csomor PA; Knappe B; Geyer MA; Quednow BB
Neuropsychopharmacology; 2007 Sep; 32(9):1876-87. PubMed ID: 17299516
[TBL] [Abstract][Full Text] [Related]
20. Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys.
Decamp E; Tinker JP; Schneider JS
Behav Brain Res; 2004 Jul; 152(2):259-62. PubMed ID: 15196793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
